Patents by Inventor Zhi BAI

Zhi BAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10457747
    Abstract: Provided is a method for obtaining high-yield, stable expression cell clones from myeloma cell lines in a protein-free culture medium. The method is used for industrial production of a recombinant antibody, and includes three stage: (1) adapting to a protein-free culture medium, statically culturing cells at a low density, and gradually reducing a fat-rich supplement to a chemical culture medium; (2) adapting to a protein-free culture medium; culturing cells at a high density, and using a perfusion fermentation system in a laboratory scale; and (3) screening high-yield, stable expression cell clones from the cells after fermentation ends. The cell clone may be used to produce a humanized anti-NeuGcGM3 14F7 recombinant antibody.
    Type: Grant
    Filed: March 11, 2016
    Date of Patent: October 29, 2019
    Assignees: BIOTECH PHARMACEUTICAL CO. LTD., CENTRO DE INMUNOLOGIA MOLECULAR
    Inventors: MeyLen Chea, Julio Palacios, Miguel Arias, Loany Calvo, Tamara González, Rolando Pérez, Zhi Bai, Yuemao Liu, Kaiheng Xiao, Xiao Chen, Zhenhua He, Yangliu Cai, Zhenhua Yang, Xianhong Bai
  • Patent number: 10365725
    Abstract: A travel-proofed portable computer keyboard with keys sealed against dust and minor impacts includes an alphanumeric keyboard, a numeric keypad, and a first locking mechanism. The alphanumeric keyboard includes an open cavity. The numeric keypad is received in or protruding from the cavity. The numeric keypad includes a first notch and a second notch. The first locking mechanism includes an engaging member which can lock the numeric keypad in place. The numeric keypad is held in the cavity of the alphanumeric keyboard when the engaging member engages the first notch of the numeric keypad, thereby facilitating the carrying of the computer keyboard. The numeric keypad is held to protrude from the cavity of the alphanumeric keyboard when the engaging member engages the second notch of the numeric keypad, thereby enabling the use of the computer keyboard.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: July 30, 2019
    Assignees: Fu Tai Hua Industry (Shenzhen) Co., Ltd., HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Ning-Hua Wang, Zhi-Bai Su
  • Publication number: 20190094986
    Abstract: A travel-proofed portable computer keyboard with keys sealed against dust and minor impacts includes an alphanumeric keyboard, a numeric keypad, and a first locking mechanism. The alphanumeric keyboard includes an open cavity. The numeric keypad is received in or protruding from the cavity. The numeric keypad includes a first notch and a second notch. The first locking mechanism includes an engaging member which can lock the numeric keypad in place. The numeric keypad is held in the cavity of the alphanumeric keyboard when the engaging member engages the first notch of the numeric keypad, thereby facilitating the carrying of the computer keyboard. The numeric keypad is held to protrude from the cavity of the alphanumeric keyboard when the engaging member engages the second notch of the numeric keypad, thereby enabling the use of the computer keyboard.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 28, 2019
    Inventors: NING-HUA WANG, ZHI-BAI SU
  • Publication number: 20180016353
    Abstract: Provided is a method for obtaining high-yield, stable expression cell clones from myeloma cell lines in a protein-free culture medium. The method is used for industrial production of a recombinant antibody, and includes three stage: (1) adapting to a protein-free culture medium, statically culturing cells at a low density, and gradually reducing a fat-rich supplement to a chemical culture medium; (2) adapting to a protein-free culture medium; culturing cells at a high density, and using a perfusion fermentation system in a laboratory scale; and (3) screening high-yield, stable expression cell clones from the cells after fermentation ends. The cell clone may be used to produce a humanized anti-NeuGcGM3 14F7 recombinant antibody.
    Type: Application
    Filed: March 11, 2016
    Publication date: January 18, 2018
    Inventors: MeyLen CHEA, Julio PALACIOS, Miguel ARIAS, Loany CALVO, Tamara GONZÁLEZ, Rolando PÉREZ, Zhi BAI, Yuemao LIU, Kaiheng XIAO, Xiao CHEN, Zhenhua HE, Yangliu CAI, Zhenhua YANG, Xianhong BAI